Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Fortis Healthcare Limited    FORTIS   INE061F01013

FORTIS HEALTHCARE LIMITED

(FORTIS)
  Report  
End-of-day quote. End-of-day quote NATIONAL STOCK EXCHANGE OF INDIA - 12/06
137.25 INR   -0.44%
11/18NEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/18NEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/18IHH Healthcare Puts Offer for India's Fortis Healthcare on Hold
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Fortis Healthcare India Ltd : India's First Successful Percutaneous TAVI Performed At Fortis Escorts

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/15/2012 | 07:35am EST
India's first successful Percutaneous TAVI performed at Fortis Escorts Cardiac surgeons team led by Dr. Ashok Seth New Delhi, February 29, 2011: India's first successful Percutaneous Transcatheter Aortic Valve Implantation (TAVI), a non-surgical, without cardiopulmonary bypass, Cath Lab based heart valve replacement procedure was performed by a team of doctors led by Dr. Ashok Seth, Chairman - Cardiac Sciences, Fortis Escorts Heart Institute. The doctors at Fortis Escorts have performed this path-breaking and revolutionary procedure on three elderly patients, over 70 year old, with severe calcified Aortic stenosis.

All three patients had severe breathlessness and heart failure, which could have been fatal. They were high- risk patients for Valve Replacement Surgery as two of them had already undergone bypass surgery and all were getting on in years. The valve implantation was performed in the Cath Lab. Each procedure took approximately two hours and was conducted through the groin in an angioplasty-like procedure, without opening the chest or putting the patient on bypass.
Dr Ashok Seth has been involved in the early stage of development of the catheter-based valve replacement procedure and performed one of the first cases in the world in 2004. While briefing the media, Dr. Ashok Seth, Chairman - Cardiac sciences, Fortis Escorts Heart institute said, "It is yet another first from the hospital which is known to undertake state-of-the-art procedures, in an effort to bring the latest and finest in healthcare treatments for patients. With this non-surgical procedure, patients who suffer from calcified aortic stenosis, which specifically increases with age, will benefit. Surgical procedures for these patients can pose a high risk, because of age and other factors."
TAVI is an alternative to open heart surgery and is considered a better alternate since it is a minimally invasive procedure. This heart surgery can be performed using echocardiographic and fluoroscopic guidance for visualization during implantation. The valve is positioned and deployed across the patient's diseased aortic valve. The patient can be discharged soon after the surgery, unlike in a bypass surgery. The patient also does not need to be on heavy medication and can resume a perfectly healthy life with the help of basic medication, regular check-ups and a proper diet.

About Fortis Escorts Heart Institute

Fortis Escorts Heart Institute, the first fully dedicated cardiac care facility in India is part of Fortis Healthcare
Ltd. Fortis Escorts Heart Institute has set benchmarks in cardiac care with its path-breaking work over the past
22 years. Today, it is recognised world over as a centre of excellence, providing the latest technology in Cardiac Bypass Surgery, Minimally Invasive Surgery (Robotics), Interventional Cardiology, Non-invasive Cardiology, Paediatric Cardiology and Paediatric Cardiac Surgery. The hospital is backed by the most advanced laboratories performing a complete range of investigative tests in the field of Nuclear Medicine, Radiology, Biochemistry, Haematology, Transfusion Medicine and Microbiology.

About Fortis Healthcare (India) Ltd.

Fortis Healthcare (India) Limited is a leading, integrated healthcare delivery provider in the Pan Asia-Pacific region. The healthcare verticals of the company span primary healthcare, speciality day care, diagnostics and hospitals, with an asset base in 10 countries, many of which represent the fastest-growing healthcare delivery markets in the world. Currently, the company operates its healthcare delivery network in Australia, Canada, Dubai, Hong Kong, India, Mauritius, New Zealand, Singapore, Sri Lanka and Vietnam with 75 hospitals, over
12,000 beds, 580 primary care centres, 191 day care speciality centres, over 210 diagnostic centres and a talent pool of over 23,000 people. Fortis is driven by the vision of becoming a global leader in the integrated healthcare delivery space and the larger purpose of saving and enriching lives through clinical excellence.

For further information, please contact: Surbhi Goel, Fortis Escorts Heart Institute ; Mob: +91 98102 11229; Email: surbhi.goel@fortishealthcare.com Abhishek Maurya /Manas Mrinal, Hanmer MSL, Mob: +91 99997 72110 / +91 99535 58197, abhishek.maurya@hanmermsl.com
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FORTIS HEALTHCARE LIMITED
11/18NEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/18NEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/18IHH Healthcare Puts Offer for India's Fortis Healthcare on Hold
DJ
06/22FORTIS HEALTHCARE : Sanjay Sinha starts new inning at Fortis Healthcare as CHRO
AQ
06/21FORTIS HEALTHCARE : appoints Sanjay Sinha as CHRO
AQ
06/16FORTIS HEALTHCARE :  Healthcare calls off process of stake sale in RHT and RHTTM
AQ
06/10FORTIS HEALTHCARE : Sebi, government sign data sharing deal to keep tabs on frau..
AQ
06/04RECEIVED APPROVAL FROM BSE AND NSE F : Fortis Healthcare
AQ
04/0489 PC WOMEN FEEL UNCOMFORTABLE ABOUT : Survey
AQ
03/15FORTIS HEALTHCARE : SC asks ex-Ranbaxy promoters to apprise it of complying with..
AQ
More news
Financials (INR)
Sales 2020 48 107 M
EBIT 2020 4 029 M
Net income 2020 2 414 M
Debt 2020 10 354 M
Yield 2020 -
P/E ratio 2020 51,5x
P/E ratio 2021 39,0x
EV / Sales2020 2,37x
EV / Sales2021 2,09x
Capitalization 104 B
Chart FORTIS HEALTHCARE LIMITED
Duration : Period :
Fortis Healthcare Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORTIS HEALTHCARE LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 171,00  INR
Last Close Price 137,30  INR
Spread / Highest target 34,7%
Spread / Average Target 24,5%
Spread / Lowest Target 9,25%
EPS Revisions
Managers
NameTitle
Ashutosh Raghuvanshi Managing Director & Chief Executive Officer
Daljit Singh President
Ravi Rajagopal Chairman
Vivek Kumar Goyal Chief Financial Officer
Ajay Vij Chief Information Officer
Sector and Competitors